6FYO
X-RAY STRUCTURE OF CLK1-KD(148-484)/Cpd-2 AT 2.32A
Summary for 6FYO
Entry DOI | 10.2210/pdb6fyo/pdb |
Related | 6FYI 6FYK 6FYL |
Descriptor | Dual specificity protein kinase CLK1, 6-~{tert}-butyl-~{N}-[6-(1~{H}-pyrazol-4-yl)-1~{H}-imidazo[1,2-a]pyridin-2-yl]pyridine-3-carboxamide, SULFATE ION, ... (4 entities in total) |
Functional Keywords | splicing, transferase, kinase, tyrosine-protein kinase, serine/ threonine- protein kinase, nucleotide-binding |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 40253.13 |
Authors | Kallen, J. (deposition date: 2018-03-12, release date: 2018-07-18, Last modification date: 2024-01-17) |
Primary citation | Kallen, J.,Bergsdorf, C.,Arnaud, B.,Bernhard, M.,Brichet, M.,Cobos-Correa, A.,Elhajouji, A.,Freuler, F.,Galimberti, I.,Guibourdenche, C.,Haenni, S.,Holzinger, S.,Hunziker, J.,Izaac, A.,Kaufmann, M.,Leder, L.,Martus, H.J.,von Matt, P.,Polyakov, V.,Roethlisberger, P.,Roma, G.,Stiefl, N.,Uteng, M.,Lerchner, A. X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome. ChemMedChem, 13:1997-2007, 2018 Cited by PubMed: 29985556DOI: 10.1002/cmdc.201800344 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.32 Å) |
Structure validation
Download full validation report